Sutro Biopharma

Biotech & Life Sciences · South San Francisco, United States · Founded 2003 · IPO 2018

Develops protein therapeutics by using OCFS protein synthesis technology

Valuation $211M

Revenue $45M

Power Law Thoroughbred$100M+ revenue

Talent graph

Sutro Biopharma's talent

Book a demo to see the people

Employees mapped 209 incl. 2 AI specialists

Founders /100 quality score

Key operators 6 quality /100

Potential founders likely future founders

Startup mafia 4 alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

11 investors on Sutro Biopharma's cap table

Sourced from Dealroom's funding and investor records.

Series A 1 investor entered at this stage

SV Health Investors

Series B+ 10 investors entered at this stage

Celgene

Tekla Capital Management

Samsara BioCapital

Vida Ventures

Amgen Ventures

Skyline Ventures

Lilly Ventures

Citadel

Merck & Co.

Alta Partners

Sutro Biopharma mafia

Startups founded by Sutro Biopharma alumni

Former Sutro Biopharma employees who went on to start their own companies. Sorted by Dealroom signal score.

InterVennEst. 2017

Lieza MarieUnited States

Signal score70

Greenlight BiosciencesEst. 2008

James SwartzUnited States

Signal score65

ActymEst. 2017

Christopher ThanosUnited States

Signal score61

eCommeraEst. 2007

Michael RossUnited Kingdom

Signal score59

Book a demo to explore the full alumni network →

Global footprint

Where Sutro Biopharma has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States99.5%

🇩🇪 Germany0.5%

2 countries shown

Web traffic by country

12K monthly visits
across markets

🇺🇸 United States52.5%

🇯🇵 Japan12.5%

🇮🇳 India11.7%

🇪🇸 Spain7.5%

🇨🇭 Switzerland4.2%

Top 5 markets shown

Patent intelligence

$83M patent portfolio · 52 active families

Estimated portfolio value

$83M

39.5% of market cap · 491.5× larger than top peer Firefly Bio ($169k)

52 active patent families

Where Sutro Biopharma innovates Antibody conjugateAntiendomysial antibodiesBiochemistryCe AntibodyDiagnostic methods

Where Sutro Biopharma concentrates vs peers

Each axis is a top-10 topic across Sutro Biopharma and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Sutro Biopharma

An AI-synthesized read of the highest-engagement posts about Sutro Biopharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sutro Biopharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles